Page last updated: 2024-10-30

leflunomide and Arthritis, Reactive

leflunomide has been researched along with Arthritis, Reactive in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Arthritis, Reactive: An aseptic, inflammatory arthritis developing secondary to a primary extra-articular infection, most typically of the GASTROINTESTINAL TRACT or UROGENITAL SYSTEM. The initiating trigger pathogens are usually SHIGELLA; SALMONELLA; YERSINIA; CAMPYLOBACTER; or CHLAMYDIA TRACHOMATIS. Reactive arthritis is strongly associated with HLA-B27 ANTIGEN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YZ1
Zhao, XZ1
Wu, J1
Mei, CL1
Thielen, AM1
Barde, C1
Janer, V1
Borradori, L1
Saurat, JH1

Reviews

1 review available for leflunomide and Arthritis, Reactive

ArticleYear
Combination regimen of leflunomide plus methylprednisolone in a female patient with reactive arthritis and concomitant IgA nephropathy.
    Chinese medical journal, 2010, Feb-05, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Arthritis, Reactive; Drug Combinations; Female; Glomerulonephritis, IGA; Humans;

2010

Other Studies

1 other study available for leflunomide and Arthritis, Reactive

ArticleYear
Reiter syndrome triggered by adalimumab (Humira) and leflunomide (Arava) in a patient with ankylosing spondylarthropathy and Crohn disease.
    The British journal of dermatology, 2007, Volume: 156, Issue:1

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Mono

2007